ASTRAZENECA PHARMA INDIA
Back to Cashflow Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-24 Cr | ₹-9.46 Cr | ₹-8.97 Cr | ₹-6.36 Cr | - |
What is the latest Cash Flow from Financing Activities ratio of ASTRAZENECA PHARMA INDIA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-24 Cr |
Mar2022 | ₹-9.46 Cr |
Mar2021 | ₹-8.97 Cr |
Mar2020 | ₹-6.36 Cr |
Mar2019 | - |
How is Cash Flow from Financing Activities of ASTRAZENECA PHARMA INDIA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-24 Cr | Negative | |
Mar2022 | ₹-9.46 Cr | Negative | |
Mar2021 | ₹-8.97 Cr | Negative | |
Mar2020 | ₹-6.36 Cr | 0 | |
Mar2019 | - | - |
Compare Cash Flow from Financing Activities of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹13,334.6 Cr | 1.4% | 0.4% | 75.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | 1.4% |
0.4% |
75.5% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses